The Epidemiology of Bile Acid Diarrhea in Denmark

References

• Wedlake L, A’Hern R, Russell D, Thomas K, Walters JRF, Andreyev HJN. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30(7):707–717. doi:10.1111/j.1365-2036.2009.04081.x
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M. Update on bile acid malabsorption: finally Ready for prime time? Curr Gastroenterol Rep. 2018;20(3):10. doi:10.1007/s11894-018-0615-z
   PubMedGoogle Scholar
• Kårhus ML, Sonne DP, Thomasen M, et al. Enterohepatic, Gluco-metabolic, and Gut microbial characterization of individuals with bile acid malabsorption. Gastro Hep Advances. 2022;1(3):299–312. doi:10.1016/j.gastha.2021.12.007
   Google Scholar
• Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther. 2014;39(9):923–939. doi:10.1111/apt.12684
   PubMed Web of Science ®Google Scholar
• Farrugia A, Attard JA, Khan S, Williams N, Arasaradnam R. Postcholecystectomy diarrhoea rate and predictive factors: a systematic review of the literature. BMJ Open. 2022;12(2):e046172. doi:10.1136/bmjopen-2020-046172
   PubMed Web of Science ®Google Scholar
• Baena García A, Partida Palma F, García Martínez S, de Bonilla Candau M, Pajares Vinardell M. 75Se-Homocholic acid taurine scintigraphy (75SeHCAT®), a standard benchmark test in bile acid malabsorption? Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019;38(5):305–311. doi:10.1016/j.remn.2018.12.005
   PubMed Web of Science ®Google Scholar
• Notghi A, O’Brien J, Low CS, Thomson W. Measuring SeHCAT retention: a technical note. Nucl Med Commun. 2011;32(10):960–966. doi:10.1097/MNM.0b013e32834a36af
   PubMed Web of Science ®Google Scholar
• Sciarretta G, Fagioli G, Furno A, et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut. 1987;28(8):970–975. doi:10.1136/gut.28.8.970
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE) Guidelines: Bile Acid. Malabsorption: Colesevelam; 2013. Available from: https://www.nice.org.uk/advice/esuom22/chapter/Key-points-from-the-evidence. Accessed November 28, 2023.
   Google Scholar
• Orekoya O, McLaughlin J, Leitao E, Johns W, Lal S, Paine P. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy. Clin Med. 2015;15(3):252–257. doi:10.7861/clinmedicine.15-3-252
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7_suppl):22–25. doi:10.1177/1403494810387965
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• World Health Organization, International classification of diseases, 10th version; January, 2023. Available from: https://icd.who.int/browse10/2016/en. Accessed November 28, 2023.
   Google Scholar
• Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7_suppl):91–94. doi:10.1177/1403494810394715
   PubMedGoogle Scholar
• Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7_suppl):103–105. doi:10.1177/1403494811405098
   PubMedGoogle Scholar
• Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39(7_suppl):38–41. doi:10.1177/1403494810394717
   PubMed Web of Science ®Google Scholar
• World Health Organization. Anatomical Therapeutic Chemical (ATC) classification. Available from: https://www.who.int/tools/atc-ddd-toolkit. Accessed November 28, 2023.
   Google Scholar
• Sahl Andersen J, De Fine Olivarius N, Krasnik A. The Danish national health service register. Scand J Public Health. 2011;39(7_suppl):34–37. doi:10.1177/1403494810394718
   PubMed Web of Science ®Google Scholar
• Kristensen KB, Lund LC, Jensen PB, et al. Development and validation of a Nordic multimorbidity index based on hospital diagnoses and filled prescriptions. Clin Epidemiol. 2022;14:567–579. doi:10.2147/CLEP.S353398
   PubMed Web of Science ®Google Scholar
• Kårhus ML, Brønden A, Forman JL, et al. Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. Lancet Gastroenterol Hepatol. 2022;7(10):922–931. doi:10.1016/S2468-1253(22)00198-4
   PubMed Web of Science ®Google Scholar
• Paré P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from logic (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study. Clin Ther. 2006;28(10):1726–1735. doi:10.1016/j.clinthera.2006.10.010
   PubMed Web of Science ®Google Scholar
• Andrae DA, Patrick DL, Drossman DA, Covington PS. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual Life Outcomes. 2013;11(1):208. doi:10.1186/1477-7525-11-208
   PubMedGoogle Scholar
• Frändemark Å, Jakobsson Ung E, Törnblom H, Simrén M, Jakobsson S. Fatigue: a distressing symptom for patients with irritable bowel syndrome. Neurogastroenterol Motil. 2017;29(1):e12898. doi:10.1111/nmo.12898
   Web of Science ®Google Scholar
• Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work productivity and activity impairment in Irritable Bowel Syndrome (IBS): a multifaceted problem. J Am Coll Gastroenterol. 2018;113(10):1540. doi:10.1038/s41395-018-0262-x
   PubMed Web of Science ®Google Scholar
• Håkanson C, Sahlberg-Blom E, Nyhlin H, Ternestedt BM. Struggling with an unfamiliar and unreliable body: the experience of irritable bowel syndrome. J Nurs Healthcare Chronic Illness. 2009;1(1):29–38. doi:10.1111/j.1365-2702.2008.01001.x
   Google Scholar
• Henriksen DP, Rasmussen L, Hansen MR, Hallas J, Pottegård A. Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use—a descriptive cross-sectional study. PLoS One. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
   PubMed Web of Science ®Google Scholar
• Kårhus ML, Brønden A, Røder ME, Leotta S, Sonne DP, Knop FK. Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide. Gastroenterology. 2019;157(2):569–571. doi:10.1053/j.gastro.2019.04.002
   PubMed Web of Science ®Google Scholar